DJ Inovio Pharmaceuticals Inc. Stock Rises Monday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ inched 0.69% higher to $4.35 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.97% to 19,403.95 and the Dow Jones Industrial Average falling 0.29% to 44,782.00.
This was the stock's third consecutive day of gains.
Inovio Pharmaceuticals Inc. closed $10.40 short of its 52-week high ($14.75), which the company reached on April 1st.
The stock outperformed some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 0.14% to $154.80, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ fell 1.49% to $25.82.
Trading volume (320,611) remained 46,714 below its 50-day average volume of 367,325.
Data source: Dow Jones Market Data, FactSet. Data compiled December 2, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
December 02, 2024 17:27 ET (22:27 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。